Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
20.65
61.11
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Gross Margin
Chongqing Zhifei Biological Products Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 66B CNY |
Gross Margin |
25%
|
Country | FR |
Market Cap | 6T USD |
Gross Margin |
0%
|
Country | US |
Market Cap | 310.2B USD |
Gross Margin |
67%
|
Country | US |
Market Cap | 142B USD |
Gross Margin |
60%
|
Country | US |
Market Cap | 115B USD |
Gross Margin |
78%
|
Country | US |
Market Cap | 101.6B USD |
Gross Margin |
86%
|
Country | US |
Market Cap | 94.1B EUR |
Gross Margin |
76%
|
Country | AU |
Market Cap | 134.4B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 78.5B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 39.3B EUR |
Gross Margin |
75%
|
Country | NL |
Market Cap | 36B EUR |
Gross Margin |
89%
|
Chongqing Zhifei Biological Products Co Ltd
Glance View
Chongqing Zhifei Biological Products Co., Ltd., nestled in the fast-paced city of Chongqing, embodies the nexus between innovative biotechnology and practical healthcare solutions. Founded amidst the booming biotech wave, Zhifei has steadily evolved into a substantial player in the vaccine and biopharmaceutical sector. The company’s core operations revolve around the research, development, production, and sales of vaccines and medical diagnostics, ensuring it caters to the surging demand for advanced healthcare solutions both domestically and internationally. Its product line spans from vaccines aimed at combating infectious diseases to diagnostic tools that aid in addressing public health challenges. Moreover, with a robust R&D wing, Zhifei continuously thrives on innovation, channeling significant investments into developing new vaccines that meet the changing needs of global health landscapes. Zhifei’s business model is tightly interwoven with the fabric of healthcare infrastructure, where its profitability hinges not just on product sales but also on strategic collaborations and licenses. Engaging in partnerships with other global pharmaceutical giants and research entities, Zhifei amplifies its market reach and technological prowess. It navigates through the intricacies of regulatory approvals and market distribution with a balanced approach through joint ventures and distribution agreements, which enhance its footprint in regions with burgeoning healthcare needs. Through a lens of sustainable growth, the company marries its entrepreneurial spirit with operational excellence, thus sustaining its ascendancy in the biopharma industry, while contributing to public health improvements worldwide.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Chongqing Zhifei Biological Products Co Ltd's most recent financial statements, the company has Gross Margin of 25.2%.